145 results
Page 2 of 8
8-K
41qu8
12 May 22
Pulmatrix Announces First Quarter 2022 Financial Results and Provides Corporate Update
9:15am
DEFA14A
r5jjfa05
2 May 22
Additional proxy soliciting materials
6:10am
8-K
EX-10.1
c5o1i2 bdi7mww8pw76
15 Apr 22
Departure of Directors or Certain Officers
4:11pm
S-8
h5ux8g4aw my
29 Mar 22
Registration of securities for employees
5:20pm
8-K
ufw1e3dqe
29 Mar 22
Pulmatrix Announces Year-End and Q4 Financial 2021 Results and Provides Corporate Update
9:15am
8-K
yy9ev5i
21 Mar 22
Pulmatrix Announces Positive Top-Line Data Evaluating PUR1800 in Patients with Stable COPD
8:15am
DEFA14A
nw50g 1881j695k8
1 Feb 22
Additional proxy soliciting materials
9:10am
DEFA14A
e2z6tkedj5nnc18 d5fd
30 Dec 21
Additional proxy soliciting materials
1:08pm
DEFA14A
EX-99.1
lyeb1271wvhho5
17 Dec 21
Additional proxy soliciting materials
5:03pm
DEFA14A
1i5rn wq13o
17 Dec 21
Additional proxy soliciting materials
5:03pm
8-K
odsqg ro360
17 Dec 21
Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering
4:40pm
8-K
EX-99.1
gpk pi1uppa2ccy1f
17 Dec 21
Pulmatrix Announces Closing of $6.75 Million Registered Direct Offering
4:40pm
DEFA14A
ywl5jr95 82dn1d2y6
17 Dec 21
Additional proxy soliciting materials
6:09am
8-K/A
a67mxawkn1w1o2
17 Dec 21
Entry into a Material Definitive Agreement
6:08am
DEFA14A
94jvgi
15 Dec 21
Additional proxy soliciting materials
5:27pm
DEFA14A
EX-99.1
nsk9w7dna
15 Dec 21
Additional proxy soliciting materials
5:27pm